Matthew W. Haley

Statistics

Publications

Citations

191

H-Index

Active since

2006

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of North Carolina at Chapel Hill

Matthew W. Haley is an author at Bristol-Myers Squibb (United States) specializing in synthetic medicinal chemistry, medicinal chemistry, and retrosynthetic analysis.

Publications per year

2006–2024

Publications

Rapid Development of a Commercial Process for Linrodostat, an Indoleamine 2,3-Dioxygenase (IDO) Inhibitor

Kenneth J. Fraunhoffer, Albert J. DelMonte, Gregory L. Beutner et al. · Organic Process Research & Development · 2019 · 38 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

Formal Synthesis of (+)-Sorangicin A

Michael T. Crimmins, Matthew W. Haley, Elizabeth A. O’Bryan · Organic Letters · 2011 · 33 citations · Full text

Natural Sciences, Chemistry, Medicinal Chemistry +10

Total Syntheses of (+)- and (−)-Tetrapetalones A and C

Heemal H. Dhanjee, Yutaka Kobayashi, J.F. Buergler et al. · Journal of the American Chemical Society · 2017 · 33 citations

Pharmacy, Medicinal Chemistry, Carbohydrate Chemistry +13

Synthesis of HIV-Maturation Inhibitor BMS-955176 from Betulin by an Enabling Oxidation Strategy

Adrian Ortiz, Maxime Soumeillant, Scott Savage et al. · The Journal of Organic Chemistry · 2017 · 28 citations

Pharmacy, Biochemistry, Medicinal Chemistry +12

Synthesis of the C29−C37 Bicyclic Ether Core of (+)-Sorangicin A

Michael T. Crimmins, Matthew W. Haley · Organic Letters · 2006 · 26 citations

Natural Sciences, Chemistry, Medicinal Chemistry +15

1–5 of 7